Grovet is moving! Due to the relocating, we will be closed from May 29 to May 31 2024. No orders will be processed or shipped during this period. However, it is possible to place your order. More information about the relocating, you can find here. If you have any questions or concerns, please do not hestitate to contact us at info@grovet.com.

Tildren 10 x 10 ml

Nr.
M110
Brand:
Audevard
Batch:
102AA
Expiry date:
28-Feb-2026
Registration number:
NL: REG NL 10079 - DE: ZNR 8-00564 - IT: AIC103601035 - FR: FR/V/7671510 7/2002 - Lux: V915/03/04/0750

Is the registration number of your country not listed? Then this product falls within the cascade control system.

Tiludronic acid (as the disodium salt) injectable for the treatment of bone and cartilage-related lameness such as that of Navicular Disease and Bone Spavin.

Disclaimer: Product in the photo may differ from the actual product.

Indication

To aid in the treatment of lameness associated with osteolytic processes observed in bone spavin and in navicular syndrome of less than 6 months.

Composition

The powder contains: Tiludronic Acid (as disodium Acid) 50 mg.
The solvent vial contains: water for injection 10 ml.
The solution after reconstitution contains: Tiludronic acid 5 mg/ml 

Instructions for use

0.1 mg of tiludronic acid per kg of body weight per day for 10 days by slow intravenous route, i.e. 1 ml per 50 kg of body weight per day of a reconstituted solution containing 5 mg/ml of tiludronic acid.

 

The reconstituted solution is obtained by adding under aseptic conditions the solvent to the powder and gently mixing them.

 

- The product should be administered over 20 to 30 seconds for 10 ml.

- The side of the site of injection must be alternated from day to day.

- The product should be used immediately and not stored after reconstitution.

- Do not exceed the recommended dosage.

Tiludronic acid 5 mg/ml
© 2024 Grovet B.V. All rights reserved.